The regulation of nanotechnology in healthcare is still evolving. Regulatory bodies like the FDA and the European Medicines Agency are developing guidelines to evaluate the safety and efficacy of nanomedicines. These guidelines cover aspects such as characterization of nanomaterials, toxicological testing, and clinical trials. Ensuring that nanotechnology-based products meet stringent regulatory standards is crucial for their safe and effective use in medical applications.
